Milestones in Dialysis
Fresenius Medical Care has been at the forefront of high-flux dialysis technology, providing nephrologists the solutions to allow for the continuous enhancement of dialysis treatment.
Milestones in Dialysis
When the Industry Asked, We Delivered.
Today, over 90 percent of the machines used in the provision of hemodialysis are manufactured by Fresenius Medical Care.
Take a look and you’ll see why over 120,000 machines have been installed throughout the United States.
Further enhancements to a revolutionary technological platform. Fresenius Medical Care introduced variable dialysate flow rates to optimize solute clearance with economic dialysate consumption. Clinical utilization was enhanced with ergonomic placement of machine modules.
Fresenius Medical Care introduced the first dialysis delivery system with microprocessor technology. The foundation for intra-dialytic monitoring, trend analysis and paperless treatment records was established with the FDS-08 — a computer system which monitored the dialysis treatment with pre-programmed parameters, recorded the treatment log and provided data for transfer to medical billing and medical information programs.
Fresenius Medical Care introduced fully programmable sodium and UF profiling capabilities further refining the ability for precise, individualized treatment prescriptions. Blood Temperature and Blood Volume Monitoring were introduced providing unique biofeedback technology designed to reduce morbidity in hemodialysis.1
Fresenius Medical Care introduced the 2008K series and continues its tradition of offering a modular design for maximum treatment versatility. Vascular Access Surveillance with OnLine Clearance with Access Flow was introduced to address the ongoing issue of vascular patency.
The 2008T machine is a ground-breaking technology for the renal industry. Through development of Clinical Data eXchange™ (CDX), users can access clinical medical information systems directly from the 2008T machine. This innovative, integrated approach provides immediate access to dialysis treatment and clinical trending data traditionally held in multiple locations. Plus, the addition of bibag® On-line Dry Bicarbonate Concentrate provides a lightweight, streamlined alternative to liquid bicarbonate jugs.
Get technical training, plus on-site and phone support to maximize your investment.
1 MP Rubin, PP Cody, RP Eisinger. “Amelioration of Hemodialysis-Associated Hypotension by the Use of Cool Dialysate.” Am J Kidney Disease 5 no. 2 (1985):124-127.
Caution: Federal (US) law restricts these devices to sale by or on the order of a physician.
Note: Read the Instructions for Use for safe and proper use of these devices. For a complete description of hazards, contraindications, side effects and precautions, see full package labeling available at www.fmcna.com.
© 2013, 2018, Fresenius Medical Care, All Rights Reserved. Fresenius Medical Care, the triangle logo, Fresenius Renal Technologies, 2008, 2008K@home, BlueStar, bibag, DIASAFE, Crit-Line, CLiC, and Clinical Data eXchange (CDX) are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. Citrasate is a registered trademark of Advanced Renal Technologies, Inc. in the United States and is used under license from Advanced Renal Technologies. All other trademarks are the property of their respective owners. P/N 102054-01 Rev D 10/2018